Global Progressive Relapsing Multiple Sclerosis Treatment Market Status and Outlook 2018-2025

August 2018 | 107 pages | ID: GD4D07ECD03EN
99Strategy

Abstracts

Report Snapshot

Key Content of Chapters (Including and can be customized, report is a semifinished version, and it takes 48-72 hours to upgrade)

Part 1: Terminology Definition, Industry Chain,Industry Dynamics & Regulations and Global Market Overview
Part 2: Upstream (Raw Materials / Components) & Manufacturing (Procurement Methods & Channels and Cost) , Major Regional Production Overview and Trade Flow
Part 3: Product Segment Overview and Market Status
Part 4: Application / End-User Segment Overview and Market Status
Part 5: Region Segment Overview and Market Status
Part 6: Product & Application Segment Production & Demand by Region
Part 7: Market Forecast by Product, Application & Region
Part 8: Company information, Products & Services and Business Operation (Sales, Cost, Margin etc.)
Part 9: Market Competition and Environment for New Entrants
Part 10: Conclusion

Market Segment as follows:

Key Companies

• Cognosci Inc
• Genzyme Corp
• MedImmune LLC
• VivaCell Biotechnology Espana SL

Market by Type

• COG-133
• GZ-402668
• Inebilizumab
• VCE-0032
• Others

Market by Application

• Clinic
• Hopital
• Others

Contents

PART 1 INDUSTRY OVERVIEW (200 USD)

1.1 Progressive Relapsing Multiple Sclerosis Treatment Industry
  1.1.1 Market Development
  1.1.2 Terminology Definition in the Report
    1.1.2.1 Production
    1.1.2.2 Demand
    1.1.2.3 Sales Revenue
    1.1.2.4 Ex-factory Price & Sales Price
    1.1.2.5 Cost
    1.1.2.6 Gross Margin
1.2 Products & Services Scope
1.3 Industry Chain
1.4 Industry Dynamics & Regulations
1.5 Global Market Overview

PART 2 UPSTREAM & PRODUCTION (200 USD)

2.1 Raw Materials / Components
2.2 Procurement Methods & Channels
2.3 Cost Structure & Manufacturing
2.4 Industry Capacity
2.5 Production Distribution by Geography
  2.5.1 Production in Major Regions / Countries
  2.5.2 Trade Flow Overview

PART 3 PRODUCT SEGMENT (400 USD)

3.1 Introduction by Type
  3.1.1 COG-133
  3.1.2 GZ-402668
  3.1.3 Inebilizumab
  3.1.4 VCE-0032
  3.1.5 Others
3.2 Market Status

PART 4 APPLICATION / END-USER SEGMENT (400 USD)

4.1 Introduction by Application
  4.1.1 Clinic
  4.1.2 Hopital
  4.1.3 Others
4.2 Market Status

PART 5 REGIONAL MARKET (600 USD)

5.1 Market Overview
5.2 by Region
  5.2.1 North America
    5.2.1.1 United States Market Size and Growth (2015-2018E)
    5.2.1.2 Canada Market Size and Growth (2015-2018E)
    5.2.1.3 Mexico Market Size and Growth (2015-2018E)
  5.2.2 Europe
    5.2.2.1 Germany Market Size and Growth (2015-2018E)
    5.2.2.2 UK Market Size and Growth (2015-2018E)
    5.2.2.3 France Market Size and Growth (2015-2018E)
    5.2.2.4 Italy Market Size and Growth (2015-2018E)
    5.2.2.5 Spain Market Size and Growth (2015-2018E)
    5.2.2.6 Netherlands Market Size and Growth (2015-2018E)
    5.2.2.7 Poland Market Size and Growth (2015-2018E)
    5.2.2.8 Belgium Market Size and Growth (2015-2018E)
    5.2.2.9 Sweden Market Size and Growth (2015-2018E)
    5.2.2.10 Austria Market Size and Growth (2015-2018E)
    5.2.2.11 Denmark Market Size and Growth (2015-2018E)
    5.2.2.12 Switzerland Market Size and Growth (2015-2018E)
    5.2.2.13 Russia Market Size and Growth (2015-2018E)
  5.2.3 Asia-Pacific
    5.2.3.1 China Market Size and Growth (2015-2018E)
    5.2.3.2 India Market Size and Growth (2015-2018E)
    5.2.3.3 Japan Market Size and Growth (2015-2018E)
    5.2.3.4 Korea Market Size and Growth (2015-2018E)
    5.2.3.5 Australia Market Size and Growth (2015-2018E)
    5.2.3.6 Indonesia Market Size and Growth (2015-2018E)
    5.2.3.7 Thailand Market Size and Growth (2015-2018E)
    5.2.3.8 Malaysia Market Size and Growth (2015-2018E)
    5.2.3.9 Singapore Market Size and Growth (2015-2018E)
    5.2.3.10 Philippines Market Size and Growth (2015-2018E)
  5.2.4 South America
    5.2.4.1 Brazil Market Size and Growth (2015-2018E)
    5.2.4.2 Argentina Market Size and Growth (2015-2018E)
    5.2.4.3 Columbia Market Size and Growth (2015-2018E)
    5.2.4.4 Chile Market Size and Growth (2015-2018E)
    5.2.4.5 Peru Market Size and Growth (2015-2018E)
    5.2.4.6 Puerto Rico Market Size and Growth (2015-2018E)
    5.2.4.7 Ecuador Market Size and Growth (2015-2018E)
  5.2.5 Middle East
    5.2.5.1 Saudi Arabia Market Size and Growth (2015-2018E)
    5.2.5.2 Iran Market Size and Growth (2015-2018E)
    5.2.5.3 UAE Market Size and Growth (2015-2018E)
    5.2.5.4 Oman Market Size and Growth (2015-2018E)
    5.2.5.5 Kuwait Market Size and Growth (2015-2018E)
    5.2.5.6 Iraq Market Size and Growth (2015-2018E)
    5.2.5.7 Turkey Market Size and Growth (2015-2018E)
  5.2.6 Africa
    5.2.6.1 South Africa Market Size and Growth (2015-2018E)
    5.2.6.2 Egypt Market Size and Growth (2015-2018E)
    5.2.6.3 Nigeria Market Size and Growth (2015-2018E)
    5.2.6.4 Algeria Market Size and Growth (2015-2018E)
    5.2.6.5 Angola Market Size and Growth (2015-2018E)
    5.2.6.6 Morocco Market Size and Growth (2015-2018E)
    5.2.6.7 Sudan Market Size and Growth (2015-2018E)

PART 6 MARKET SUBDIVISION (800 USD)

6.1 Regional Production
  6.1.1 Production by Type
    6.1.1.1 COG-133 Production by Region
    6.1.1.2 GZ-402668 Production by Region
    6.1.1.3 Inebilizumab Production by Region
    6.1.1.4 VCE-0032 Production by Region
    6.1.1.5 Others Production by Region
  6.1.2 Production by Application
    6.1.2.1 Clinic Production by Region
    6.1.2.2 Hopital Production by Region
    6.1.2.3 Others Production by Region
6.2 Regional Demand
  6.2.1 Demand by Type
    6.2.1.1 COG-133 Demand by Region
    6.2.1.2 GZ-402668 Demand by Region
    6.2.1.3 Inebilizumab Demand by Region
    6.2.1.4 VCE-0032 Demand by Region
    6.2.1.5 Others Demand by Region
  6.2.2 Demand by Application
    6.2.2.1 Clinic Demand by Region
    6.2.2.2 Hopital Demand by Region
    6.2.2.3 Others Demand by Region

PART 7 MARKET FORECAST (200 USD)

7.1 Global Forecast
7.2 Forecast by Type
7.3 Forecast by Application
7.4 Forecast by Region

PART 8 KEY COMPANIES LIST (600 USD)

8.1 Cognosci Inc
  8.1.2 Company Information
  8.1.2 Products & Services
  8.1.3 Business Operation
8.2 Genzyme Corp
  8.2.1 Company Information
  8.2.2 Products & Services
  8.2.3 Business Operation
8.3 MedImmune LLC
  8.3.1 Company Information
  8.3.2 Products & Services
  8.3.3 Business Operation
8.4 VivaCell Biotechnology Espana SL
  8.4.1 Company Information
  8.4.2 Products & Services
  8.4.3 Business Operation

PART 9 COMPANY COMPETITION (500 USD)

9.1 Market by Company
9.2 Price & Gross Margin
9.3 Competitive Environment for New Entrants
  9.3.1 Michael Porter's Five Forces Model
  9.3.2 SWOT

PART 10 RESEARCH CONCLUSION (100 USD)

List Of Tables

LIST OF TABLES

Table Progressive Relapsing Multiple Sclerosis Treatment Industry Dynamics & Regulations List
Table Global Progressive Relapsing Multiple Sclerosis Treatment Sales Revenue, Cost and Margin, 2015-2018E
Table Global Progressive Relapsing Multiple Sclerosis Treatment Market Status by Type 2015-2018E, in USD Million
Table Global Progressive Relapsing Multiple Sclerosis Treatment Market Status by Application 2015-2018E, in USD Million
Table Global Progressive Relapsing Multiple Sclerosis Treatment Market Status by Application 2015-2018E, in Volume
Table Global Progressive Relapsing Multiple Sclerosis Treatment Market by Region 2015-2018E, in USD Million
Table Global Progressive Relapsing Multiple Sclerosis Treatment Market Share by Region in 2018, in USD Million
Table Global Progressive Relapsing Multiple Sclerosis Treatment Market by Region 2015-2018E, in Volume
Table Global Progressive Relapsing Multiple Sclerosis Treatment Market Share by Region in 2018, in Volume
Table COG-133 Production Value by Region 2015-2018E, in USD Million
Table COG-133 Production Volume by Region 2015-2018E, in Volume
Table GZ-402668 Production Value by Region 2015-2018E, in USD Million
Table GZ-402668 Production Volume by Region 2015-2018E, in Volume
Table Inebilizumab Production Value by Region 2015-2018E, in USD Million
Table Inebilizumab Production Volume by Region 2015-2018E, in Volume
Table VCE-0032 Production Value by Region 2015-2018E, in USD Million
Table VCE-0032 Production Volume by Region 2015-2018E, in Volume
Table Others Production Value by Region 2015-2018E, in USD Million
Table Others Production Volume by Region 2015-2018E, in Volume
Table Clinic Production Value by Region 2015-2018E, in USD Million
Table Clinic Production Volume by Region 2015-2018E, in Volume
Table Hopital Production Value by Region 2015-2018E, in USD Million
Table Hopital Production Volume by Region 2015-2018E, in Volume
Table Others Production Value by Region 2015-2018E, in USD Million
Table Others Production Volume by Region 2015-2018E, in Volume
Table COG-133 Market Size by Region 2015-2018E, in USD Million
Table COG-133 Market Size by Region 2015-2018E, in Volume
Table GZ-402668 Market Size by Region 2015-2018E, in USD Million
Table GZ-402668 Market Size by Region 2015-2018E, in Volume
Table Inebilizumab Market Size by Region 2015-2018E, in USD Million
Table Inebilizumab Market Size by Region 2015-2018E, in Volume
Table VCE-0032 Market Size by Region 2015-2018E, in USD Million
Table VCE-0032 Market Size by Region 2015-2018E, in Volume
Table Others Market Size by Region 2015-2018E, in USD Million
Table Others Market Size by Region 2015-2018E, in Volume
Table Clinic Market Size by Region 2015-2018E, in USD Million
Table Clinic Market Size by Region 2015-2018E, in Volume
Table Hopital Market Size by Region 2015-2018E, in USD Million
Table Hopital Market Size by Region 2015-2018E, in Volume
Table Others Market Size by Region 2015-2018E, in USD Million
Table Others Market Size by Region 2015-2018E, in Volume
Table GlobalProgressive Relapsing Multiple Sclerosis Treatment Forecast by Type 2019F-2025F, in USD Million
Table Progressive Relapsing Multiple Sclerosis Treatment Forecast by Type 2019F-2025F, in Volume
Table Progressive Relapsing Multiple Sclerosis Treatment Market Forecast by Application / End-User 2019F-2025F, in USD Million
Table Progressive Relapsing Multiple Sclerosis Treatment Market Forecast by Application / End-User 2019F-2025F, in Volume
Table Progressive Relapsing Multiple Sclerosis Treatment Market Forecast by Region 2019F-2025F, in USD Million
Table Progressive Relapsing Multiple Sclerosis Treatment Market Forecast by Region 2019F-2025F, in Volume
Table Cognosci Inc Information
Table Progressive Relapsing Multiple Sclerosis Treatment Sales, Cost, Margin of Cognosci Inc
Table Genzyme Corp Information
Table Progressive Relapsing Multiple Sclerosis Treatment Sales, Cost, Margin of Genzyme Corp
Table MedImmune LLC Information
Table Progressive Relapsing Multiple Sclerosis Treatment Sales, Cost, Margin of MedImmune LLC
Table VivaCell Biotechnology Espana SL Information
Table Progressive Relapsing Multiple Sclerosis Treatment Sales, Cost, Margin of VivaCell Biotechnology Espana SL
Table Global Progressive Relapsing Multiple Sclerosis Treatment Sales Revenue by Company 2015-2017, in USD Million
Table Global Progressive Relapsing Multiple Sclerosis Treatment Sales Volume by Company 2015-2017, in Volume
Table Global Progressive Relapsing Multiple Sclerosis Treatment Sales Volume by Company in 2018, in Volume

List Of Figures

LIST OF FIGURES

Figure Progressive Relapsing Multiple Sclerosis Treatment Picture
Figure Progressive Relapsing Multiple Sclerosis Treatment Industry Chain Diagram
Figure Global Progressive Relapsing Multiple Sclerosis Treatment Sales Revenue 2015-2018E, in USD Million
Figure Global Progressive Relapsing Multiple Sclerosis Treatment Sales Volume 2015-2018E, in Volume
Figure Global Progressive Relapsing Multiple Sclerosis Treatment Market Status by Type 2015-2018E, in Volume
Figure North America Progressive Relapsing Multiple Sclerosis Treatment Market Size and Growth 2015-2018E, in USD Million
Figure North America Progressive Relapsing Multiple Sclerosis Treatment Market Size and Growth 2015-2018E, in Volume
Figure Europe Progressive Relapsing Multiple Sclerosis Treatment Market Size and Growth 2015-2018E, in USD Million
Figure Europe Progressive Relapsing Multiple Sclerosis Treatment Market Size and Growth 2015-2018E, in Volume
Figure Asia-Pacific Progressive Relapsing Multiple Sclerosis Treatment Market Size and Growth 2015-2018E, in USD Million
Figure Asia-Pacific Progressive Relapsing Multiple Sclerosis Treatment Market Size and Growth 2015-2018E, in Volume
Figure South America Progressive Relapsing Multiple Sclerosis Treatment Market Size and Growth 2015-2018E, in USD Million
Figure South America Progressive Relapsing Multiple Sclerosis Treatment Market Size and Growth 2015-2018E, in Volume
Figure Middle East Progressive Relapsing Multiple Sclerosis Treatment Market Size and Growth 2015-2018E, in USD Million
Figure Middle East Progressive Relapsing Multiple Sclerosis Treatment Market Size and Growth 2015-2018E, in Volume
Figure Africa Progressive Relapsing Multiple Sclerosis Treatment Market Size and Growth 2015-2018E, in USD Million
Figure Africa Progressive Relapsing Multiple Sclerosis Treatment Market Size and Growth 2015-2018E, in Volume
Figure Global Progressive Relapsing Multiple Sclerosis Treatment Sales Revenue Forecast 2019F-2025F, in USD Million
Figure Global Progressive Relapsing Multiple Sclerosis Treatment Sales Volume Forecast 2019F-2025F, in Volume
Figure Global Progressive Relapsing Multiple Sclerosis Treatment Sales Price Forecast 2019F-2025F
Figure Global Progressive Relapsing Multiple Sclerosis Treatment Gross Margin Forecast 2019F-2025F
Figure Global Progressive Relapsing Multiple Sclerosis Treatment Sales Revenue by Company in 2018, in USD Million
Figure Global Progressive Relapsing Multiple Sclerosis Treatment Price by Company in 2018
Figure Global Progressive Relapsing Multiple Sclerosis Treatment Gross Margin by Company in 2018